Methods for determining drug candidates
AssigneeMosaiques Diagnostics and Therapeutics AG
InventorsMarika MOKOU, Harald MISCHAK
Life of this patent
Estimating the term…
Loading patent…
AssigneeMosaiques Diagnostics and Therapeutics AG
InventorsMarika MOKOU, Harald MISCHAK
Estimating the term…
The present invention relates in a first aspect to a method for determining candidate molecules for treating a disease, disorder or condition associated with tissue alteration. In particular, the method refers to determining candidate molecules for treating bladder cancer in different stages of the disease, including an in silico prediction of drug response based on reversion of a disease specific molecular signature. For example, the CMap analysis is applied on data sets obtained based on proteomics and transcriptomics analyses. In a further aspect, the present invention relates to candidate molecules useful for treating said disease, disorder or condition at different stages of disease, in particular, allowing reversal of a more severe stage of disease to a more moderate stage or to stop progression to aggressive phenotypes like aggressive phenotype of bladder cancer. Finally, drug candidates useful in the treatment of said disease, in particular, the treatment of bladder cancer are provided.
A method for determining candidate molecules for treating a disease, disorder or condition associated with tissue alteration, like a tumor, in particular bladder cancer (BC) at different stages of said disease, disorder or condition comprising in silico prediction of drug response, based on reversion of a disease specific molecular signature, in particular, applying CMap analysis based on data obtained by
Dependencies are inferred from the claim text.